Ironwood Pharmaceuticals ironwoodpharma.com


Public lists: Pharma Startups (4732)

Ironwood (formally known as Mircobia) creates and develops human medicines.

Ironwood (formally known as Mircobia) creates and develops human medicines.

Company (IPO / Went public)

Phone: 617-621-7722

Fax: 617.494.0908

320 Bent Street

Cambridge, 02141
Massachusetts, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Ironwood Pharmaceuticals $495.3M Feb 12, 2010
See all 15 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Ironwood Pharmaceuticals Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 18 investors

Competitors

Company Status Description Investors

Ribozyme Pharmaceuticals

Folsom, California, United States
Alive / ActiveRibozyme Pharmaceuticals offers RNA-based pharmaceuticals for human diseaseLogin to see details

Vitae Pharmaceuticals

Fort Washington, Pennsylvania, United States
AcquiredVitae Pharmaceuticals is a clinical stage biopharmaceutical company discovering and developing a portfolio of small molecule compounds that address disease areas, including: chronic kidney disease, diabetes, Alzheimer's disease and atherosclerosis. Vitae's lead compound, VTP-27999, is a potent and selective renin inhibitor offering the potential for superior renal protection in patients suffering from chronic kidney disease. Vitae's discovery platform has advantages in creating and analyzing dru...Show allLogin to see details
See all 15 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Imidazotriazinone compounds Dec 21, 2016 May 15, 2018 Patent
Methods and compositions for the treatment of gastrointestinal disorders Nov 09, 2015 Dec 12, 2017 Patent
Salts, co-crystals, and polymorphs of an anxiolytic compound Mar 14, 2014 Aug 29, 2017 Patent
Imidazotriazinone compounds Sep 18, 2014 Aug 08, 2017 Patent
Treatments for gastrointestinal disorders Aug 17, 2012 Jul 18, 2017 Patent
See all 73 patents